Physician profile
Simi Kalani
NPI 1588986988
$5,270.81
in general payments reported to CMS, 2019-2025
13 companies · $659 in 2025
The $659 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $856 · 2022: $1,445 · 2023: $1,082 · 2024: $1,229 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,970.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,969.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,882.99 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $943.78 | 2022-2024 | Caplyta |
| Corium, LLC | $724.11 | 2022-2025 | Azstarys |
| Axsome Therapeutics, INC. | $463.14 | 2024-2025 | Auvelity |
| Supernus Pharmaceuticals, INC. | $309.40 | 2021-2024 | Qelbree |
| Otsuka America Pharmaceutical, INC. | $245.28 | 2023-2024 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $178.40 | 2021 | |
| Collegium Pharmaceutical, INC. | $147.76 | 2025 | Jornay Pm |
| Alkermes, INC. | $145.93 | 2023-2025 | Aristada, Aristada Initio, Lybalvi |
| Tris Pharma INC | $94.54 | 2022-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $64.52 | 2024 | |
| Janssen Pharmaceuticals, INC | $36.56 | 2023 | Spravato |
| Vanda Pharmaceuticals INC. | $34.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simi Kalani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.